SHPH - Shuttle Pharma Company Projected Revenue

shuttlepharma.com - graphic logo of issuer SHPH

Shuttle Pharmaceuticals (SHPH) currently relies on investments in clinical trials, yet strategically aims for leadership by developing innovative sensitizers for brain tumor therapy. The organization's sales forecast on this GURU.Markets platform chart demonstrates this balance, where 0.00 shapes the current metric. The asset's price action ignores macroeconomics, relying exclusively on the interim success of small molecule development.

SHPH - shuttlepharma.com Company Future Revenue over the range 04/28/2023 - 11/13/2026

Comprehensive metric breakdowns and analytics for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

- stock value and consensus price forecast:
Price Chart Shuttle Pharmaceuticals|SHPH - Broker Consensus Forecast
- market capitalization statistics:
Market Value Shuttle Pharmaceuticals Holdings, Inc.|SHPH - Company Buyout Price
- balance sheet equity data:
Book Value per Share Shuttle Pharmaceuticals|SHPH - Accounting Value of Company|Market Cap to Net Assets Ratio shuttlepharma.com|SHPH - Company Total Assets
- debt and liquidity details:
Total Debt to Equity Ratio Shuttle Pharmaceuticals|SHPH - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Ratio Shuttle Pharma|SHPH - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio Shuttle Pharmaceuticals Holdings, Inc.|SHPH - Company Long-Term Debt|Company Short-Term Debts Shuttle Pharmaceuticals|Quick Liquidity Indicator shuttlepharma.com
- earnings and market ratios statistics:
SHPH - Final Profit|Expected Profit Shuttle Pharmaceuticals|SHPH - Market Cap to Net Income|Forward P/E Multiple Shuttle Pharmaceuticals Holdings|SHPH - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Shuttle Pharmaceuticals Holdings, Inc.|SHPH - Operating profit EBITDA|Earnings per share for the last twelve months Shuttle Pharmaceuticals|SHPH - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months shuttlepharma.com|SHPH - Net earnings per share growth this year|Earnings growth forecast for next year Shuttle Pharmaceuticals
- sales volume and revenue information:
SHPH - Revenue and Sales Volume|Projected Sales Volume Shuttle Pharmaceuticals|SHPH - Market Cap to Revenue|Forward P/S Multiple Shuttle Pharmaceuticals Holdings, Inc.
Summary company analysis:SHPH Shuttle Pharmaceuticals
Product sample of Shuttle Pharmaceuticals Inc

Investors must filter out speculative noise when assessing the prospects of Shuttle Pharmaceuticals (SHPH). Patent protection for radiosensitizers used in brain cancer therapy establishes a foundation of operational resilience. An analysis of the company's expected sales volume allows for the verification of market equilibrium, excluding artificial price manipulations. The metric compares daily demand points with fundamental sales models. This confirms the investment attractiveness of the business prior to the commercial launch of the drugs.

Competing companies

Company Projected Revenue CNS Pharmaceuticals (CNSP)